BioPharma Pharma & Biopharma Manufacturing
Agilent Acquires BIOVECTRA for $925 Million, Expanding Biopharma Capabilities
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing...
July 23, 2024 | News
DiscGenics Receives FDA Approval to Proceed with Phase III Clinical Trials for Regenerative Cell Therapy for Lumbar Degenerative Disc Disease
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoske...
July 23, 2024 | News
Everest Medicines Doses First Chinese Patient in Global Phase 2b Trial of Zetomipzomib for Lupus Nephritis
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
July 22, 2024 | News
ACROBiosystems Launches Resilient Supply Brand to Boost Cell and Gene Therapy Development at ISSCR Annual Meeting
At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Res...
July 19, 2024 | News
CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Sanyou Bio and Huadong Medicine Advance SYHD001 ADC Drug to Phase I Clinical Trials
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") has recently announced a significant milestone in collaboration wi...
July 17, 2024 | News
Everest Medicines Announces Positive Topline Data from Phase 3 Trial of Etrasimod for Ulcerative Colitis in Asia
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
July 16, 2024 | News
Merck Life Science Launches First GMP Compliant Manufacturing Line for Cell Culture Media in China
Merck Life Science is thrilled to announce the commencement of commercial production at our first Good Manufacturing Practice (GMP) compliant manuf...
July 16, 2024 | News
Porton J-STAR Secures Two-Year Contract with Enabling Technologies Consortium for Co-Processing Platform Development
Porton J-STAR announced that Enabling Technologies Consortium (ETC) has awarded a two-year contract to J-STAR to collaborate on "Co-processing Platfo...
July 10, 2024 | News
CBC Group and Hasten Biopharmaceutical Acquire Asset Rights of 14 Branded Products from Celltrion in Major Pan-Asia Expansion
CBC Group (“CBC”), Asia’s largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its control...
July 01, 2024 | News
Thermo Fisher Scientific Introduces Biobased Films for Bioprocessing Containers to Enhance Sustainability in Biologics Manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, is contributing to the sustainability of biologics therapy manufacturing by leveraging ...
July 01, 2024 | News
Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability
Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...
July 01, 2024 | News
Cytiva Introduces Supor Prime Filters to Enhance High-Concentration Biologic Drug Manufacturing
Global life sciences leader Cytiva is addressing the distinct filtration needs of customers manufacturing high-concentration biologic drugs with its Supor ...
June 28, 2024 | News
Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.
Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...
June 25, 2024 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
